0.50 CME

AIRH Dialogues with the Change Makers in Healthcare AI – Dr. Dwarikanath Mahapatra

Speaker: Dr. Dwarikananth Mahapatra

AI Scientist & Consultant, Prof. Khalifa University, Abu Dhabi Emirate, United Arab Emirates

Login to Start

Description

Artificial Intelligence is rapidly transforming healthcare by enhancing diagnostic accuracy, enabling personalized treatment strategies, and supporting data-driven clinical decision-making. In this AIRH Dialogue, Dr. Dwarikanath Mahapatra explores how AI is reshaping modern medicine across multiple specialties, from medical imaging and predictive analytics to clinical decision support and precision healthcare. The session also examines the opportunities and challenges associated with AI adoption, including ethical considerations, data privacy, and regulatory frameworks. Through practical insights and real-world applications, participants will gain a deeper understanding of how AI is driving innovation, improving patient outcomes, and paving the way for a more connected, efficient, and future-ready healthcare ecosystem.

Summary Listen

  • Clinicians increasingly face proposals for medical imaging and broader healthcare artificial intelligence intended to support diagnosis and workflow. A framework for trustworthy AI was emphasized around three practical questions: whether the system works for patients in real clinical settings, whether clinicians know when to trust or not trust its outputs, and what occurs when the system fails or produces unexpected results.
  • For clinical validity and robustness, performance must be assessed against data that resemble the local patient population and imaging environment. Benchmarking on curated datasets may overestimate real-world performance, particularly when training and evaluation differ by scanner manufacturer, image quality, labeling practices, or patient characteristics. Trustworthiness also depends on uncertainty awareness and explainability. A reliable system should provide calibrated confidence (for example, an 80% confidence statement should correspond to approximately 80% correctness under similar conditions) and use evidence to support its decision. Explainability should move beyond heatmaps or plausible-sounding language to a medically meaningful chain of reasoning that links imaging findings to conclusions, considers alternative diagnoses, and communicates uncertainty.
  • Deployment introduces additional challenges not present in laboratory settings. Key issues include data gaps (messy, non-standardized hospital data and variable image quality), workflow gaps (the model may be correct but used at the wrong step or fail to match clinician needs within the overall clinical process), and trust gaps (clinicians may reject AI outputs due to unclear responsibility, uncertainty, or limited transparency). Consequently, deployment is not an endpoint; models require post-deployment governance, monitoring, audit logs, and mechanisms to identify performance drift by population or time, with predefined processes for updates when accreditation windows limit rapid change.
  • Management principles highlighted included incorporating calibrated uncertainty estimation, out-of-distribution detection with “I don’t know” responses, human-in-the-loop escalation for flagged cases, and continuous performance monitoring after rollout. Looking forward, multimodal clinical agents combining imaging, reports, prior scans, and longitudinal data may enable more interactive, evidence-grounded, time-aware decision support, improving access and triage where specialist resources are limited—provided they remain robust, fair, and safety-governed.

Comments